Raleigh Hematology Oncology — Raleigh, North Carolina

Raleigh Hematology Oncology is a clinical research site located in Raleigh, North Carolina, United States 27609.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Raleigh Hematology Oncology has participated in 1 clinical trials.

Therapeutic areas: Renal Cell Carcinoma, Metastases.

Sponsors: Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Raleigh Hematology Oncology?

Raleigh Hematology Oncology has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Raleigh Hematology Oncology conducted?

Raleigh Hematology Oncology has 1 clinical trials on record. Their work covers Renal Cell Carcinoma, Metastases.

Is Raleigh Hematology Oncology accredited by Crixeo Health?

Raleigh Hematology Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Raleigh Hematology Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.